New combo pill aims to tackle high blood pressure
NCT ID NCT05385770
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This Phase 3 trial tested whether taking two blood pressure medications (AZM and AML) together works better than taking either one alone. About 890 adults with mild-to-moderate high blood pressure took part. The study lasted 8 weeks and compared different doses of the combination against single drugs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AZM and AML (blood pressure medications)
What this could lead to
If successful, this could offer a more effective two-drug combination for controlling high blood pressure with a single daily pill.
What could go wrong
This is a completed Phase 3 trial, but results are not yet published. The combination may not be significantly better than each drug alone, and side effects could be higher.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celltrion
Incheon, South Korea